Jakavi Tablets 15mg

Product Description

Jakavi Tablets 15mg contain ruxolitinib, a Janus kinase (JAK) inhibitor used to treat specific blood disorders by targeting abnormal signaling pathways in the bone marrow and immune system.

Product Overview

Product Name: Jakavi Tablets 15mg
Product Form: Tablets
Pack Size: 56's
Manufactured By: Novartis
Used For: Treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease
Prescription Required: Yes

How It Works

Ruxolitinib inhibits JAK enzymes, which are involved in signaling pathways that regulate blood cell production and immune responses. By targeting these pathways, Jakavi helps normalize blood cell production, reduce inflammation, and manage immune overactivity associated with blood disorders.

Key Benefits

Manages symptoms and progression of myelofibrosis
Provides therapy for polycythemia vera in patients at risk of blood clotting due to excess red blood cells
Treats graft-versus-host disease after stem cell transplantation
Reduces fatigue, spleen enlargement, and other complications associated with abnormal blood cell production

How to Use

Take Jakavi Tablets exactly as prescribed by your doctor
Swallow the tablet whole with water, usually twice daily, or as directed by your healthcare provider
Regular monitoring of blood counts and liver function is essential during treatment

Side Effects and Precautions

Common Side Effects

Anemia (low red blood cell count)
Thrombocytopenia (low platelet count)
Neutropenia (low white blood cell count)
Dizziness or lightheadedness
Headache
High blood pressure
Elevated liver enzymes
Weight gain
Fatigue
Increased risk of infections

Precautions

Regular blood tests to monitor blood cell counts and liver function
Inform your doctor of any history of infections, liver disease, or other significant health conditions
Avoid live vaccines during treatment
Report signs of infection immediately, including fever, chills, or persistent sore throat
Provide a complete list of all medications to your healthcare provider to avoid interactions, especially blood thinners and certain antifungals
Use effective contraception during treatment, as Jakavi may harm an unborn baby

Who Should Use

Patients diagnosed with myelofibrosis, polycythemia vera, or graft-versus-host disease under specialist supervision

Storage Instructions

Store in a cool, dry place away from direct sunlight
Keep out of reach of children and use before the expiry date

Disclaimer

This medication must be used under medical supervision. The information provided does not replace professional medical advice. Always consult your doctor for diagnosis, treatment planning, and correct dosing instructions